Diagnosis of Carcinogenic Pathologies through Breath Biomarkers: Present and Future Trends
Open Access
- 11 November 2023
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 11 (11) , 3029
Abstract
The assessment of volatile breath biomarkers has been targeted with a lot of interest by the scientific and medical communities during the past decades due to their suitability for an accurate, painless, non-invasive, and rapid diagnosis of health states and pathological conditions. This paper reviews the most relevant bibliographic sources aiming to gather the most pertinent volatile organic compounds (VOCs) already identified as putative cancer biomarkers. Here, a total of 265 VOCs and the respective bibliographic sources are addressed regarding their scientifically proven suitability to diagnose a total of six carcinogenic diseases, namely lung, breast, gastric, colorectal, prostate, and squamous cell (oesophageal and laryngeal) cancers. In addition, future trends in the identification of five other forms of cancer, such as bladder, liver, ovarian, pancreatic, and thyroid cancer, through perspective volatile breath biomarkers are equally presented and discussed. All the results already achieved in the detection, identification, and quantification of endogenous metabolites produced by all kinds of normal and abnormal processes in the human body denote a promising and auspicious future for this alternative diagnostic tool, whose future passes by the development and employment of newer and more accurate collection and analysis techniques, and the certification for utilisation in real clinical scenarios.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (UIDB/04559/2020 (LIBPhys), UIDP/04559/2020 (LIBPhys), PD/BDE/150627/2020)
This publication has 161 references indexed in Scilit:
- A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditionsBritish Journal of Cancer, 2013
- Identification of volatile lung cancer markers by gas chromatography–mass spectrometry: comparison with discrimination by caninesAnalytical and Bioanalytical Chemistry, 2012
- Personalized cancer medicine – A strategy to counteract an increasing cancer challengeMolecular Oncology, 2012
- Cancer biomarkersMolecular Oncology, 2012
- Diagnosis of head-and-neck cancer from exhaled breathBritish Journal of Cancer, 2011
- Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensorsBritish Journal of Cancer, 2010
- Gastric cancerCritical Reviews in Oncology/Hematology, 2009
- Extending the breadth of metabolite profiling by gas chromatography coupled to mass spectrometryTrAC Trends in Analytical Chemistry, 2008
- Cancer biomarkers: a systems approachNature Biotechnology, 2006
- Diagnostic potential of breath analysis—focus on volatile organic compoundsClinica Chimica Acta, 2004